eli lilly tirzepatide pill weight-loss orforglipron could get FDA approval in 2026, CEO Dave Ricks says FDA approval of Eli Lilly's

Three practical takeaways 1 CLA and L-carnitine can be combined and the idea makes biochemical sense

We know from animal studies that directly record from neurons in this region of the brain that GLP-1 does suppress activity of this region of the brain, and this suppression is likely associated with the reduction in food noise that patients with obesity often report

doi: 10.3390/antiox12081626

The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), 6-hydroxydopamine (6-OHDA), and 5-S-cysteinyl-dopamine (CysDA) models each target dopaminergic neurons and increase oxidative damage to the brain, providing valuable insight to the efficacy of mitigating oxidative stress as a mechanism of sulforaphanes neuroprotective effects